All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen and Novartis , said they signed on to participate in the talks by the Oct. 1 deadline. https://t.co/vHywKTaIGL — Reuters Health (@Reuters_Health) October 3, 2023 Yep, looks like it’ll be nothing but …
Wednesday Morning Open Thread: In *Other* News…Post + Comments (234)